Target intelligence / Profile preview

Ribosomal protein L5 pseudogene 16 (RPL5P16)

Target: RPL5P16
Molecular classification: Other (Pseudogene)

Overview

Ribosomal protein L5 pseudogene 16 (*RPL5P16*) is a nonfunctional genomic sequence derived from the ribosomal protein L5 gene. It does not encode an active protein, nor is it associated with any known biological pathways, molecular interactions, or direct disease involvement. Pseudogenes like RPL5P16 are distributed throughout the human genome as remnants of gene duplication or retrotransposition events and typically do not serve as molecular targets in pharmacology or clinical research[4][8].

Other names: RPL5_7_588RPL5P16

Beyond the preview

Go deeper on Ribosomal protein L5 pseudogene 16 (RPL5P16).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Explore the programs pursuing this target and their development progress.

Drug candidates
Developers
Development stage

Clinical trials

Follow the clinical studies evaluating therapies directed at this target.

Trial design
Status
Readouts

Competitive landscape

Compare approaches across drug candidates, modalities, and indications.

Programs
Modalities
Indications

Literature & evidence

Investigate the research and source evidence behind target biology and development.

Publications
Sources
Analysis

Patents

Explore patent activity around therapies and technologies addressing this target.

Patents
Assignees
Technologies

Research & analysis

Connect target biology, drug development, and emerging evidence in your research.

Biology
Development news
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Ribosomal protein L5 pseudogene 16 (RPL5P16).

Explore the full profile